Related by context. Frequent words. (Click for all words.) 68 Patient Enrollment 66 Phase III Trial 66 Clinical Trial Results 64 RNAi Therapeutics 63 Presents Positive 63 Phase III Clinical Trial 62 Drug Candidate 62 Pivotal Phase III 62 Inc Therapeutic Competitors 62 Pivotal Trial 61 Shareholder Letter 61 Preclinical Data 61 Completes Enrollment 61 Vicor Technologies 60 Prostate Cancer Patients 60 Metastatic Melanoma 60 FDA Accepts 60 Well Tolerated 59 Patient Outcomes 59 Pivotal Phase 59 CR# vcMMAE 59 Summarizes 58 Pulmonary Arterial Hypertension 58 2nd Quarter Results 58 Venous Thromboembolism 58 II Clinical Trial 58 Upcoming Conferences 58 FY# Guidance 58 SABCS 57 Initiate Phase 57 Significant Increase 57 Preliminary Third Quarter 57 Diabetic Macular Edema 57 Small Molecule 57 Performance Metrics 57 Announces Presentation 56 BioDelivery Sciences 56 Updates Shareholders 56 Phase Ib clinical 56 Annual Meeting Date 56 Exploit collaboration 56 Metastatic Colorectal Cancer 56 3rd Quarter Results 56 Phase 1b 56 FDA Clears 56 Gastric Cancer 56 Phase Ib 56 CCX# 56 Smallpox Vaccine 56 www.syntapharma.com 56 1st Quarter Results 56 Chronic Hepatitis C 55 Shareholder Update 55 Malaria Vaccine 55 Phase 1b trial 55 AeroLEF TM 55 Provides Updates 55 Acute Coronary Syndromes 55 Pharmacokinetic 55 Patients Treated 55 Announces Initiation 55 Solid Tumors 55 Epratuzumab 55 Initiates Phase 55 Immunogenicity 55 Chronic Heart Failure 55 Closes Financing 55 Heart Failure Patients 55 Record Fourth Quarter 55 Arch Neurol 54 Vertex Pharmaceuticals Announces 54 Record Third Quarter 54 Survival Rates 54 Guidance Quick Facts 54 Successful Completion 54 Explore Strategic Alternatives 54 Hold Third Quarter 54 Achieves Milestone 54 FDA Orphan Drug 54 Phase IIb trials 54 Record Second Quarter 54 elotuzumab 54 www.methylgene.com 54 Malignancies 54 Full Prescribing Information 54 Diabetic Patients 54 Clinical Outcomes 54 Operational Results 54 Updates Guidance 54 Exclusive License 54 Monoclonal Antibody 54 Study Demonstrates 53 Recombinant Human 53 Cholesterol Drug 53 www.labopharm.com 53 Combination Therapy 53 Announces Publication 53 Releases Third Quarter 53 Progress Toward 53 Detailed Product 53 Preliminary Fourth Quarter